The Robotic Surgeon Blog

  • UGNJ to Host Prostate Cancer Awareness Event

    June-12-2013 Prostate-Cancer-Awareness-and-Survivorship I will be one of the speakers at our prostate cancer survivorship even on June 12th. This will be held at our cancer center on June 12th. This event will be open to the public and will feature physicians discussing many aspects of prostate cancer treatment and care.

  • Nephron-Sparing Treatments Underused in CKD Patients – Renal and Urology News

    Of particular concern, the researchers noted, is that patients with pre-existing chronic kidney disease (CKD) had a nearly twofold increased likelihood of undergoing RN than NSM compared with patients without CKD. Even though NSM use increased over the study period, most CKD patients still received RN, the investigators found. via Nephron-Sparing Treatments Underused in CKD…

  • AUA: Five tests, treatments may be unnecessary | Urology Times

    The AUA’s list identified the following five recommendations: A routine bone scan is unnecessary in men with low-risk prostate cancer. Do not prescribe testosterone to men with erectile dysfunction who have normal testosterone levels. Do not order creatinine or upper tract imaging in men with BPH. Do not treat an elevated PSA with antibiotics for…

  • Intuitive Robot Probe Threatens Trend-Setting Surgeries – Bloomberg

    The safety of robots made by Intuitive Surgical Inc. (ISRG) is being probed by U.S. regulators, raising questions about the prospects of one of the hottest technologies in health care. The Food and Drug Administration asked surgeons at key hospitals to list the complications they may have seen with the machines, which cost about $1.5…

  • BBC News – TED 2013: Uchek app tests urine for medical issues

    Uchek tests for 25 different health issues and could help diagnose and treat diseases in the developing world.Increasingly mobile health is being talked up as a lifesaver in such areas.The app is the brainchild of TED fellow Myshkin Ingawale.”I wanted to get medical health checks into users hands,” he told the BBC. via BBC News…

  • FDA approves Botox to treat overactive bladder

    FDA approves Botox to treat overactive bladder The U.S. Food and Drug Administration today expanded the approved use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics. via Press Announcements > FDA approves Botox to treat overactive bladder. Men…

  • Partial Nephrectomy Offers Better Renal Preservation, Survival – Renal and Urology News

    The median follow-up for patients still alive at the last follow-up was 8.3 years. The estimated overall survival rates at 10 and 15 years were 69% and 53%, respectively, for RN compared with 80% and 74%, respectively, following PN. Compared with PN-treated patients, patients who underwent RN were 75% more likely to die from any…

  • Europe Gives Nod to Prostate Cancer Pill Before Chemo

    The European Medicines Agencys Committee for Medicinal Products for Human Use CHMP has recommended extending the use of the prostate cancer pill abiraterone acetate Zytiga, Janssen to include men with advanced prostate cancer who fail on androgen-deprivation therapy.The drug is currently approved in Europe and the United States for these same men, but only as…

  • Green Tea May Inhibit Prostate Cancer Tumor Growth – Renal and Urology News

    Drinking green tea may play a role in the inhibition of prostate cancer tumor growth, according to a study presented at the American Association for Cancer Research’s International Conference on Frontiers in Cancer Prevention Research in Anaheim, Calif. via Green Tea May Inhibit Prostate Cancer Tumor Growth – Renal and Urology News. Green tea is…